Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.
Journal Information
Full Title: Can Respir J
Abbreviation: Can Respir J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure All authors declare no relationship with Carinopharm GmbH, Elze, Germany, the licensee of Perfan® (enoximone, intravenous solution). Conflicts of Interest J. B. and P. B. are scientific/clinical advisors and shareholders in BMR BV. Relatives of A. K. are shareholders of BMR B.V."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025